Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Methodological comparison between salivary and plasma inflammatory biomarkers in third molar surgery patients
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences.ORCID iD: 0009-0002-1818-7347
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.ORCID iD: 0000-0003-3161-0402
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences.ORCID iD: 0000-0002-3178-4210
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
Keywords [en]
Saliva, Plasma, Biomarkers, Cytokines, Inflammation, Inflammation mediators, Pain
National Category
Clinical Laboratory Medicine
Identifiers
URN: urn:nbn:se:uu:diva-566628OAI: oai:DiVA.org:uu-566628DiVA, id: diva2:1996488
Available from: 2025-09-09 Created: 2025-09-09 Last updated: 2025-10-09
In thesis
1. A clinical trial of S-ketamine analgesia in third molar surgery: Effects, safety and influence on inflammatory biomarkers
Open this publication in new window or tab >>A clinical trial of S-ketamine analgesia in third molar surgery: Effects, safety and influence on inflammatory biomarkers
2025 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Background and aims: Third molar surgery is a common surgical procedure and a well-established pain model in research, which is generally performed under local anaesthesia. Post-operative pain management is often solved with a combination of paracetamol and ibuprofen. In this thesis, our goal was to find a better alternative for pain management in the early post-operative period.  The overall aim was to study if preoperative IV S-ketamine (0.125mg/kg or 0.25mg/kg) can offer a more effective and safer transition from local anaesthesia to orally administered analgesia, to investigate whether surgery or S-ketamine have an impact on inflammatory biomarkers in plasma, and to examine differences in protein expression between saliva and plasma. 

Patients and methods: 168 patients participated in the study. Physiological variables, questionnaires, pain diaries, and self-reported side effects were all registered in the study. Biomarkers in plasma and saliva were analysed using a multiplex panel (Olink).

Results: There was a globally significant lower pain score in the group with high dose S-ketamine, and a longer time to first rescue medication. There were minor, clinically insignificant changes of SpO2 and pulse rate in the S-ketamine 0.25 mg/kg group.  Surgery significantly affected certain biomarkers (IL6, CST5, OSM, TGF-alpha, IL10, FGF-19, Flt3L, white blood cell count, neutrophil blood cell count, cortisol, and high sensitivity c-reactive protein). S-ketamine had no impact on the expression of biomarkers. Although major differences were observed in biomarker expression between saliva and plasma, the correlations were ultimately limited and weak.

Conclusion:  A single dose of S-ketamine 0.25 mg/kg IV reduces postoperative pain for up to 24h with a longer time to first rescue medication, compared to S -ketamine 0.125 mg/kg and placebo. Single dose S-ketamine 0.25 mg/kg IV gives a minor reduction of SpO2 and a minor increase of pulse rate at the end of infusion of S-ketamine. These changes are clinically insignificant. Third molar surgery causes an immune response within 2 hours expressed in plasma; infusion of S-ketamine 0.25 or 0.125 mg/kg does not cause any immune reaction. The immune response in saliva vs plasma differs and are not interchangeable.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2025. p. 103
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2194
Keywords
Pain, Postoperative pain, S-ketamine, Third molar surgery, Efficacy, Safety, Biomarkers, Inflammatory biomarkers, Plasma, Saliva.
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:uu:diva-566983 (URN)978-91-513-2621-4 (ISBN)
Public defence
2025-12-03, Bibliotekets föreläsningssal, Falu lasarett, Söderbaums väg 8, Falun, 13:00 (Swedish)
Opponent
Supervisors
Available from: 2025-11-06 Created: 2025-10-09 Last updated: 2025-11-26

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Eriksson, Lars BLarsson, AndersEriksson, MatsTegelberg, ÅkeThor, AndreasGordh, Torsten
By organisation
Department of Surgical SciencesDepartment of Medical Sciences
Clinical Laboratory Medicine

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 52 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf